Literature DB >> 23706222

Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis.

Vuk Uskoković1, Charles Hoover, Marija Vukomanović, Dragan P Uskoković, Tejal A Desai.   

Abstract

Development of a material for simultaneous sustained and localized delivery of antibiotics and induction of spontaneous regeneration of hard tissues affected by osteomyelitis stands for an important clinical need. In this work, a comparative analysis of the bacterial and osteoblastic cell response to two different nanoparticulate carriers of clindamycin, an antibiotic commonly prescribed in the treatment of bone infection, one composed of calcium phosphate and the other comprising poly-(D,L-lactide-co-glycolide)-coated calcium phosphate, was carried out. Three different non-cytotoxic phases of calcium phosphate, exhibiting dissolution and drug release profiles in the range of one week to two months to one year, respectively, were included in the analysis: monetite, amorphous calcium phosphate and hydroxyapatite. Spherical morphologies and narrow size distribution of both types of nanopowders were confirmed in transmission and scanning electron microscopic analyses. The antibiotic-containing powders exhibited sustained drug release contingent upon the degradation rate of the carrier. Assessment of the antibacterial performance of the antibiotic-encapsulated powders against Staphylococcus aureus, the most common pathogen isolated from infected bone, yielded satisfactory results both in broths and on blood agar plates for all the analyzed powders. In contrast, no cytotoxic behavior was detected upon the incubation of the antibiotic powders with the osteoblastic MC3T3-E1 cell line for up to three weeks. The cells were shown to engage in a close contact with the antibiotic-containing particles, irrespective of their internal or surface phase composition, polymeric or mineral. At the same time, both types of particles upregulated the expression of osteogenic markers osteocalcin, osteopontin, Runx2 and protocollagen type I, suggesting their ability to promote osteogenesis and enhance remineralization of the infected site in addition to eliminating the bacterial source of infection.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23706222      PMCID: PMC3672472          DOI: 10.1016/j.msec.2013.04.023

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  40 in total

1.  Structural modeling of drug release from biodegradable porous matrices based on a combined diffusion/erosion process.

Authors:  V Lemaire; J Bélair; P Hildgen
Journal:  Int J Pharm       Date:  2003-06-04       Impact factor: 5.875

Review 2.  Tissue engineering strategies for bone regeneration.

Authors:  Amit S Mistry; Antonios G Mikos
Journal:  Adv Biochem Eng Biotechnol       Date:  2005       Impact factor: 2.635

3.  How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment.

Authors:  Juergen Siepmann; Khaled Elkharraz; Florence Siepmann; Diana Klose
Journal:  Biomacromolecules       Date:  2005 Jul-Aug       Impact factor: 6.988

4.  Osteolytic changes accompanying degradation of absorbable fracture fixation implants.

Authors:  O M Böstman
Journal:  J Bone Joint Surg Br       Date:  1991-07

Review 5.  Antimicrobial options in the treatment of adult staphylococcal bone and joint infections in an era of drug shortages.

Authors:  Allison L Mruk; Kenneth E Record
Journal:  Orthopedics       Date:  2012-05       Impact factor: 1.390

6.  Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.

Authors:  Angela Celetti; Domenico Testa; Stefania Staibano; Francesco Merolla; Valentina Guarino; Maria Domenica Castellone; Renata Iovine; Gelsomina Mansueto; Pasquale Somma; Gaetano De Rosa; Vieri Galli; Rosa Marina Melillo; Massimo Santoro
Journal:  Clin Cancer Res       Date:  2005-11-15       Impact factor: 12.531

7.  Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers.

Authors:  O Böstman; E Hirvensalo; J Mäkinen; P Rokkanen
Journal:  J Bone Joint Surg Br       Date:  1990-07

8.  Osteoinductive potential of freeze-dried, biodegradable, poly (glycolic acid-co-lactic acid) disks incorporated with bone morphogenetic protein in skull defects of rats.

Authors:  T Miki; Y Imai
Journal:  Int J Oral Maxillofac Surg       Date:  1996-10       Impact factor: 2.789

9.  Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells.

Authors:  Sang Wan Kim; Sun Ju Her; Seong Jae Park; Dohee Kim; Kyong Soo Park; Hong Kyu Lee; Byung Hee Han; Min Seon Kim; Chan Soo Shin; Seong Yeon Kim
Journal:  Bone       Date:  2005-09       Impact factor: 4.398

10.  Actinomycotic osteomyelitis of the facial bones and mandible.

Authors:  A Yenson; H O deFries; Z E Deeb
Journal:  Otolaryngol Head Neck Surg       Date:  1983-04       Impact factor: 3.497

View more
  17 in total

Review 1.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

Review 2.  Nanomedicine for safe healing of bone trauma: Opportunities and challenges.

Authors:  Shahed Behzadi; Gaurav A Luther; Mitchel B Harris; Omid C Farokhzad; Morteza Mahmoudi
Journal:  Biomaterials       Date:  2017-09-04       Impact factor: 12.479

Review 3.  [Bone substitute materials as local drug carriers : Current status of substitutes of various origins].

Authors:  K-D Kühn; C Berberich; H Bösebeck
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

4.  In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  J Pharm Sci       Date:  2013-12-30       Impact factor: 3.534

Review 5.  When 1+1>2: Nanostructured composites for hard tissue engineering applications.

Authors:  Vuk Uskoković
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-08-01       Impact factor: 7.328

Review 6.  Multifunctional coatings to simultaneously promote osseointegration and prevent infection of orthopaedic implants.

Authors:  Jordan Raphel; Mark Holodniy; Stuart B Goodman; Sarah C Heilshorn
Journal:  Biomaterials       Date:  2016-01-18       Impact factor: 12.479

7.  Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-01-10       Impact factor: 7.328

Review 8.  Nanoparticulate drug delivery platforms for advancing bone infection therapies.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Expert Opin Drug Deliv       Date:  2014-08-11       Impact factor: 6.648

9.  Chitosan-PLGA polymer blends as coatings for hydroxyapatite nanoparticles and their effect on antimicrobial properties, osteoconductivity and regeneration of osseous tissues.

Authors:  Nenad Ignjatović; Victoria Wu; Zorica Ajduković; Tatjana Mihajilov-Krstev; Vuk Uskoković; Dragan Uskoković
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-11-24       Impact factor: 7.328

10.  Population Effects of Calcium Phosphate Nanoparticles in Drosophila melanogaster: The Effects of Phase Composition, Crystallinity, and the Pathway of Formation.

Authors:  Victoria M Wu; Vuk Uskoković
Journal:  ACS Biomater Sci Eng       Date:  2017-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.